Most Recent Articles from Biotech Financial Reports

• ENCORIUM REPORTS 2ND QTR 2009 NET REVENUE OF 4.5 MILLION.(Company overview)(Financial report) 

  Encorium Group, Inc. (NASDAQ:ENCO), Wayne, Pa., a full service multinational contract research organization (CRO) that provides design,...

  10/01/09 · More from publication

• ANGEION INCREASES GROSS MARGIN 54.45% FOR FISCAL 2009 3RD QTR.(Financial report) 

  For the 2009 third quarter, Angeion, St. Paul, Minn., posted a net loss of $173,000, or $0.04 per diluted share, on revenues of $6.2 million....

  10/01/09 · More from publication

• ANADYS REPORTS NET LOSS OF $6.5 MILLION 2ND QTR 2009.(Financial report) 

  Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS), San Diego, Calif., a biopharmaceutical company dedicated to improving patient care by developing...

  09/01/09 · More from publication

• UNITED THERAPEUTICS HAS NET LOSS OF $2.3 MIL 2ND QTR 2009.(Financial report) 

  United Therapeutics Corporation (NASDAQ:UTHR), Silver Spring, Md., has announced its results of operations for the quarter ended June 30, 2009....

  09/01/09 · More from publication

• ROCHESTER MEDICAL REPORTS 3RD QTR NET LOSS OF $77.000.(Financial report) 

  Rochester Medical Corporation (NASDAQ:ROCM), Stewartville, Minn., has announced operating results for its third quarter ended June 30, 2009. ...

  09/01/09 · More from publication

• ZILA REPORTS FISCAL 2009 3RD QTR NET REVENUES OF $8.5 MIL.(Financial report) 

  Zila, Inc. (Nasdaq:ZILA), Scottsdale, Ariz., has reported financial results for its fiscal 2009 third quarter ended April 30, 2009. "During the...

  07/01/09 · More from publication

View more »